Evotope Biosciences

Evotope Biosciences is a biotechnology company dedicated to advancing the field of extracellular vesicle (EV) therapeutics through precision engineering. The company's proprietary platform enables the modification of exosome surfaces to facilitate the targeted delivery of therapeutic cargoes, such as nucleic acids and proteins, to specific tissues. By utilizing naturally occurring vesicles, Evotope's approach offers improved biocompatibility and reduced immunogenicity compared to synthetic delivery systems. The company is currently focused on developing a pipeline of candidates for oncology and central nervous system disorders. Evotope aims to transform the treatment landscape for complex diseases by overcoming traditional drug delivery challenges.